Dr. Sue Brown, CDT Endocrinologist and protocol chair of DCLP3, presented the study’s results at the annual American Diabetes Association Scientific Sessions this past Sunday, June 9th. DCLP3, or the Diabetes Closed-Loop Protocol 3 study investigated the use Tandem’s Control-IQ hybrid closed loop, embedded within a t:slim X2 pump and utilizing the Dexcom G6 continuous glucose monitor. A report on the trial and its results can be found here.
Following the presentation, Dr. Brown along with CDT Director, Boris Kovatchev, were interviewed by JDRF.
Boris Kovatchev and Dr. Sue Brown discuss the exciting results of the Special Diabetes Program (SDP) funded iDCL trial using the Tandem DexCom Control IQ system. This is just one of many reasons it’s so important that we #RenewSDP! #JDRFxADA pic.twitter.com/y3GnulH9ng
— JDRF Research (@JDRFResearch) June 10, 2019
One conference attendee (Stephen Stone, MD @diabetesninja) created a sketch to represent Dr. Brown’s presentation and some of the study’s results.
#MicDrop at #ADA2019 @TandemDiabetes @typezerotech Control-IQ achieves 70% time-in-range during a 6 month trial. Watch out 670G! #Sketchnotes #InsulinPump #T1D pic.twitter.com/xP1ehSCoB4
— Stephen Stone, MD (@DiabetesNinja) June 9, 2019